| Previous Close | 37.95 |
| Open | 37.92 |
| Bid | 34.00 x 100 |
| Ask | 37.42 x 100 |
| Day's Range | 37.41 - 38.07 |
| 52 Week Range | 35.15 - 46.80 |
| Volume | 3,336,574 |
| Avg. Volume | 2,829,314 |
| Market Cap | 10.5B |
| Beta | 0.52 |
| PE Ratio (TTM) | 13.42 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Markit•yesterdaySee what the IHS Markit Score report has to say about Hologic Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Thomson Reuters StreetEvents•7 days ago
Edited Transcript of HOLX earnings conference call or presentation 2-Aug-17 8:30pm GMT
Q3 2017 Hologic Inc Earnings Call
Capital Cube•7 days agoHologic, Inc. – Value Analysis (NASDAQ:HOLX) : August 12, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Hologic, Inc. a score of 53. Our analysis is based on comparing Hologic, Inc. with the following peers – Thermo Fisher Scientific Inc., Becton, Dickinson and Company, C. R. Bard, Inc., Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson, Quest Diagnostics Incorporated, General Electric Company and Royal ... Read more (Read more...)
